A Phase 1 Study of Sunitinib Malate [sunitinib] in Combination With Cisplatin/Capecitabine or Oxaliplatin/Capecitabine in Patients With Advanced Gastric Cancer.

Next Previous
Trial Profile

A Phase 1 Study of Sunitinib Malate [sunitinib] in Combination With Cisplatin/Capecitabine or Oxaliplatin/Capecitabine in Patients With Advanced Gastric Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Oct 2013

At a glance

  • Drugs Capecitabine; Cisplatin; Oxaliplatin; Sunitinib
  • Indications Gastric cancer
  • Focus Adverse reactions

    • Most Recent Events

    • 27 Dec 2011 Actual end date Dec 2011 added as reported by ClinicalTrials.gov.
    • 27 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Nov 2011 Planned end date changed from 1 Oct 2011 to 1 Nov 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top